{"entity":{"type":"insider","cik":"0001903865","url":"/insider/0001903865","json_url":"/insider/0001903865.json","name":"Khan Samina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":3,"first":"2023-03-06","last":"2023-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Khan Samina","source":"filing","n_filings":3,"first_seen":"2023-03-06","last_seen":"2023-05-17"}],"transactions":[{"id":8153559,"accession":"0001209191-23-030192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030192","line_url":"/filing/0001209191-23-030192#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001903865","owner_name":"Khan Samina","owner_display_name":"Khan Samina","owner_url":"/insider/0001903865","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":352.0,"shares_display":"352","price_per_share":81.368,"price_display":"81.37","price_state":"stated","total_value":28641.536,"total_display":"28,641.54","total_whole":"28,642","shares_owned_after":39491.0,"shares_owned_after_display":"39,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8153556,"accession":"0001209191-23-030192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030192","line_url":"/filing/0001209191-23-030192#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001903865","owner_name":"Khan Samina","owner_display_name":"Khan Samina","owner_url":"/insider/0001903865","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":288.0,"shares_display":"288","price_per_share":85.32,"price_display":"85.32","price_state":"stated","total_value":24572.16,"total_display":"24,572.16","total_whole":"24,572","shares_owned_after":39843.0,"shares_owned_after_display":"39,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8035590,"accession":"0001209191-23-017220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017220","line_url":"/filing/0001209191-23-017220#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001903865","owner_name":"Khan Samina","owner_display_name":"Khan Samina","owner_url":"/insider/0001903865","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3961.0,"shares_display":"3,961","price_per_share":83.46,"price_display":"83.46","price_state":"stated","total_value":330585.06,"total_display":"330,585.06","total_whole":"330,585","shares_owned_after":40131.0,"shares_owned_after_display":"40,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8106124,"accession":"0001209191-23-016306","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-016306","line_url":"/filing/0001209191-23-016306#line-5","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001903865","owner_name":"Khan Samina","owner_display_name":"Khan Samina","owner_url":"/insider/0001903865","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2813.0,"shares_display":"2,813","price_per_share":87.36,"price_display":"87.36","price_state":"stated","total_value":245743.68,"total_display":"245,743.68","total_whole":"245,744","shares_owned_after":44092.0,"shares_owned_after_display":"44,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":8106120,"accession":"0001209191-23-016306","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-016306","line_url":"/filing/0001209191-23-016306","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001903865","owner_name":"Khan Samina","owner_display_name":"Khan Samina","owner_url":"/insider/0001903865","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":84.8788896,"price_display":"84.88","price_state":"stated","total_value":2121972.24,"total_display":"2,121,972.24","total_whole":"2,121,972","shares_owned_after":49554.0,"shares_owned_after_display":"49,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (SVP, Chief Medical Officer)","n_filings":3,"first_seen":"2023-03-06","last_seen":"2023-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001903865","retrieved_at":"2026-08-27T15:31:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}